Stock-based compensation decreased 26.0%
Stock-based compensation changed -26.0% from the comparable as-filed period.
$342,000→$253,0003 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →AWRE financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Shares outstanding increased 2.3%
Shares outstanding changed +2.3% from the comparable as-filed period. The change ranks at the 43th percentile of 7 prior comparable changes.
21,373,696→21,871,7377 prior comparisons
Current ratio decreased 10.8%
Current ratio changed -10.8% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
3.36→34 prior comparisons
Research & development increased 7.7%
Research & development changed +7.7% from the comparable as-filed period.
$2.1M→$2.3M3 prior comparisons
Cost of revenue decreased 10.6%
Cost of revenue changed -10.6% from the comparable as-filed period.
$491,000→$439,0003 prior comparisons
Capital expenditure changed across a zero base
Capital expenditure changed from 0 to 0 USD in the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a zero base.
$0→$03 prior comparisons
Current liabilities decreased 10.0%
Current liabilities changed -10.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$6.3M→$5.7M4 prior comparisons
Current ratio decreased 18.6%
Current ratio changed -18.6% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
4.59→3.734 prior comparisons
Research & development increased 29.2%
Research & development changed +29.2% from the comparable as-filed period.
$2.0M→$2.5M3 prior comparisons
Cost of revenue increased 53.4%
Cost of revenue changed +53.4% from the comparable as-filed period.
$339,000→$520,0003 prior comparisons
Shares outstanding increased 2.3%
Shares outstanding changed +2.3% from the comparable as-filed period. The change ranks at the 57th percentile of 7 prior comparable changes.
21,314,235→21,812,6377 prior comparisons
Stock-based compensation decreased 15.7%
Stock-based compensation changed -15.7% from the comparable as-filed period.
$381,000→$321,0003 prior comparisons
Capital expenditure changed across a zero base
Capital expenditure changed from 0 to 0 USD in the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a zero base.
$0→$04 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.